Invention Grant
- Patent Title: Therapeutic agents for the treatment of HBV infection
-
Application No.: US15896285Application Date: 2018-02-14
-
Publication No.: US10239872B2Publication Date: 2019-03-26
- Inventor: Yi Chen , Yan Lou
- Applicant: Newave Pharmaceutical Inc.
- Applicant Address: US CA Pleasanton
- Assignee: Newave Pharmaceutical Inc.
- Current Assignee: Newave Pharmaceutical Inc.
- Current Assignee Address: US CA Pleasanton
- Agency: McCarter & English, LLP
- Agent Yu Lu; Wei Song
- Main IPC: C07D455/06
- IPC: C07D455/06 ; C07D471/04 ; A61P31/20 ; C07D498/04
Abstract:
The disclosure includes compounds of Formula (I) wherein Z1, Z2, Z3, X, R1, R2, R3, R4, R5, R6, and R7 are defined herein. Also disclosed is a method for treating HBV infection.
Public/Granted literature
- US20180170925A1 NOVEL THERAPEUTIC AGENTS FOR THE TREATMENT OF HBV INFECTION Public/Granted day:2018-06-21
Information query
